Choksi Laboratories Share Price
164.15-2.25 (-1.35%)
-20.99% past 1 Year
Choksi Laboratories Limited (CLL) is widely known as a leading analysis and research group providing complete solutions for improving quality in processes products and services.The company is a contract testing
Corporate filings & documents
Announcements
Submission of newspaper clipping for the Notice of 33rd Annual General Meeting of the company
1 week agoSubmission of newspaper clipping for the Notice of 33rd Annual General Meeting of the company
1 week agoSubmission of intimation for dispatch of letter regarding notice of upcoming AGM to those shareholders whose email addresses are not registered with the company/RTA or depositories
1 week agoSubmission of intimation for dispatch of letter regarding notice of upcoming AGM to those shareholders whose email addresses are not registered with the company/RTA or depositories
1 week agoSubmission of Annual Report for the F.Y. 2025-26
1 week agoSubmission of Annual Report for the F.Y. 2025-26
1 week agoSubmission of Notice convening 33rd AGM of the company to be held on 18th September 2026 at 12:30 p.m. through Video conference/Other Audio Visual means
1 week agoSubmission of Notice convening 33rd AGM of the company to be held on 18th September 2026 at 12:30 p.m. through Video conference/Other Audio Visual means
1 week agoIntimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA
1 week agoIntimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA
1 week agoSubmission of newspaper clipping of information regarding 33rd Annual General Meeting of the company
2 weeks agoSubmission of newspaper clipping of information regarding 33rd Annual General Meeting of the company
2 weeks agoNewspaper publication of unaudited financial result for the quarter ended 30th June 2026
3 weeks agoNewspaper publication of unaudited financial result for the quarter ended 30th June 2026
3 weeks agoReappointment of Internal Auditor for the F.Y. 2026-27
3 weeks agoReappointment of Internal Auditor for the F.Y. 2026-27
3 weeks agoReappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.
3 weeks agoReappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.
3 weeks agoConsidered and approved the unaudited financial results of the company for the quarter ended 30th June. 2026
3 weeks agoConsidered and approved the unaudited financial results of the company for the quarter ended 30th June. 2026
3 weeks ago1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June 2026 along with the Limited review report;2. Decided the date for closure of Register of Members and share transfer Books of the Company from Saturday 12th September 2026 to Friday 18th September 2026 (both days inclusive) for the purpose of 33rd Annual General Meeting;3. The Board has also discussed the other operational financial and administrative matters in detail and passed the necessary resolution.
3 weeks ago1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June 2026 along with the Limited review report;2. Decided the date for closure of Register of Members and share transfer Books of the Company from Saturday 12th September 2026 to Friday 18th September 2026 (both days inclusive) for the purpose of 33rd Annual General Meeting;3. The Board has also discussed the other operational financial and administrative matters in detail and passed the necessary resolution.
3 weeks agoChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter ended on 30th June 2026;2. To consider the appointment of Internal Auditor of the Company for the F.Y. 2026-27;3. To consider the matters relating to the ensuing Annual General Meeting;4. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any
4 weeks agoChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter ended on 30th June 2026;2. To consider the appointment of Internal Auditor of the Company for the F.Y. 2026-27;3. To consider the matters relating to the ensuing Annual General Meeting;4. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any
4 weeks agoNewspaper publication of information regarding change of RTA
1 month agoNewspaper publication of information regarding change of RTA
1 month agoIntimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015
1 month agoIntimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015
1 month agoSubmission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
2 months agoSubmission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
2 months agoIntimation for Closure of trading window w.e.f. 01st July 2026
2 months agoIntimation for Closure of trading window w.e.f. 01st July 2026
2 months agoSubmission of newspaper publication of financial result for the period ended 31.03.2026
3 months agoSubmission of newspaper publication of financial result for the period ended 31.03.2026
3 months agoSubmission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.2026
3 months agoResult as attached
3 months agoResult as attached
3 months ago1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March 2026 along with the along with the Auditors Report thereon Statement of Assets and Liabilities and Cash Flow Statement;2. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March 2025 as required under Regulation 24A of SEBI (LODR) 2015;3. Other routine businesses with the permission of chair.
3 months ago1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March 2026 along with the along with the Auditors Report thereon Statement of Assets and Liabilities and Cash Flow Statement;2. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March 2025 as required under Regulation 24A of SEBI (LODR) 2015;3. Other routine businesses with the permission of chair.
3 months agoThe clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 30
3 months agoThe clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 30
3 months agoIntimation for appointment of Mrs. Stela Choksi as Chief Financial Officer of the company
3 months agoIntimation for resignation of Mr. Vyangesh Choksi as Chief Financial Officer of the company
3 months agoIntimation for resignation of Mr. Vyangesh Choksi as Chief Financial Officer of the company
3 months ago1. Considered and reviewed for purchasing of 1 MG Windsor car in the name of company along with loan facilities from HDFC bank.2. Discussed and approved for initiating the process of change in Registrar and Share Transfer Agent of the Company from MUFG Intime India Private Limited to Ankit Consultancy Private Limited;3. Considered and appoved the name of Mrs. Stela Choksi as Chief Financial Officer of the company;4. Taken on record the resignation of Mr. Vyangesh Choksi as Chief Financial Officer of the company;5. Other routine businesses with the permission of chair.
3 months agoChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve 1.To consider and approve the standalone Audited Financial Result of the Company for the fourth Quarter and Year ended on 31st March 2026;2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any.
3 months agoChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve 1.To consider and approve the standalone Audited Financial Result of the Company for the fourth Quarter and Year ended on 31st March 2026;2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any.
3 months agoChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve 1.To consider and approve the purchase of Car for the business purposes of the Company and to avail credit facilities from Bank for financing the said vehicle.;2.To consider and approve the change of Registrar and Share Transfer Agent (RTA) of the Company;3. Other matters as mentioned in the notice.
3 months agoChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve 1.To consider and approve the purchase of Car for the business purposes of the Company and to avail credit facilities from Bank for financing the said vehicle.;2.To consider and approve the change of Registrar and Share Transfer Agent (RTA) of the Company;3. Other matters as mentioned in the notice.
3 months agoSubmission of scrutinizer report along with voting result of e-voting done by shareholder by means of postal ballot
4 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Survey No 9/1 Near Tulsiyana Industrial Park Gram Kumerdi Indore Madhya Pradesh PIN: 453555 Tel No: 0731-3501112 Fax No: 0731 2490593 Email: [email protected] Internet: www.choksilab.in
Registrars
Plot No. 60, Electronic Complex, Pardeshipura, Indore (M.P.)-452010 Plot No 60 Electronic Complex Pardeshipura PIN: Tel No: NULL Fax No: NULL Email: NULL
Management
Prakhar Dubey, Company Secretary & Compliance Officer
Sunil Choksi, Chairman & Managing Director
Sunil Choksi, Chairman & Managing Director
Stela Choksi, Whole Time Director & Chief Financial Officer
Himika Choksi, Whole Time Director
Vyangesh Choksi, Whole Time Director
Abha Shastri, Non Executive Independent Director
Raghmendra Singh, Non Executive Independent Director
Prachi Mantri, Non Executive Independent Director
Ritik Pavecha, Non Executive Independent Director
Details
BSE 526546
NSE NULL
ISIN INE493D01013